These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 1830911)

  • 1. [ACE inhibition: mechanisms of cardioprotection in heart hypertrophy].
    Motz W; Strauer BE
    Klin Wochenschr; 1991; 69 Suppl 24():39-43; discussion 43-4. PubMed ID: 1830911
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Medical repair of hypertensive left ventricular remodeling.
    Motz WH; Scheler S; Strauer BE
    J Cardiovasc Pharmacol; 1992; 20 Suppl 1():S32-6. PubMed ID: 1380616
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Regression of left heart hypertrophy in arterial hypertension: principles, experimental and clinical findings].
    Klaus D
    Z Kardiol; 1985; 74 Suppl 7():153-69. PubMed ID: 2936016
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regression of cardiac hypertrophy with drug treatment in spontaneously hypertensive rats.
    Ruskoaho H
    Med Biol; 1984; 62(5):263-76. PubMed ID: 6152298
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Angiotensin converting enzyme inhibition and dihydropyridine calcium channel blockade in the treatment of left ventricular hypertrophy in arterial hypertension.
    Palmieri V; Devereux RB
    Minerva Cardioangiol; 2002 Jun; 50(3):169-74. PubMed ID: 12107398
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of quinapril, losartan and hydralazine on cardiac hypertrophy and beta-adrenergic neuroeffector mechanisms in transgenic (mREN2)27 rats.
    Zolk O; Flesch M; Schnabel P; Teisman AC; Pinto YM; van Gilst WH; Paul M; Böhm M
    Br J Pharmacol; 1998 Feb; 123(3):405-12. PubMed ID: 9504380
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of hypertensive heart disease with ACE inhibitors.
    Stumpe KO
    J Cardiovasc Pharmacol; 1987; 10 Suppl 6():S166-71. PubMed ID: 2485024
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The influence of sympathetic nervous activity on regression of cardiac hypertrophy.
    Strauer BE; Bayer F; Brecht HM; Motz W
    J Hypertens Suppl; 1985 Dec; 3(4):S39-44. PubMed ID: 2937889
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Regression of biochemical changes in heart muscle hypertrophy].
    Zähringer J
    Z Kardiol; 1985; 74 Suppl 7():119-26. PubMed ID: 2868582
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relation of renin-angiotensin system activity to left ventricular hypertrophy and function in experimental and human hypertension.
    Devereux RB; Pickering TG; Cody RJ; Laragh JH
    J Clin Hypertens; 1987 Mar; 3(1):87-103. PubMed ID: 3033158
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiovascular hypertrophy in diabetic spontaneously hypertensive rats: optimizing blockade of the renin-angiotensin system.
    Lassila M; Davis BJ; Allen TJ; Burrell LM; Cooper ME; Cao Z
    Clin Sci (Lond); 2003 Apr; 104(4):341-7. PubMed ID: 12653675
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Antihypertensive treatment and left ventricular hypertrophy].
    Agabiti-Rosei E; Muiesan ML; Rizzoni D
    Ann Ital Med Int; 1993 Oct; 8 Suppl():97S-103S. PubMed ID: 8117529
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Insulin-like growth factor-1 and cardiac mass in essential hypertension: comparative effects of captopril, lisinopril and quinapril.
    Díez J; Laviades C
    J Hypertens Suppl; 1994 Jul; 12(4):S31-6. PubMed ID: 7965272
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Renin-angiotensin inhibition reverses advanced cardiac remodeling in aging spontaneously hypertensive rats.
    Ito N; Ohishi M; Yamamoto K; Tatara Y; Shiota A; Hayashi N; Komai N; Yanagitani Y; Rakugi H; Ogihara T
    Am J Hypertens; 2007 Jul; 20(7):792-9. PubMed ID: 17586415
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Angiotensin-converting-enzyme inhibitor and heart hypertrophy].
    Riegger AJ; Kromer EP
    Wien Med Wochenschr; 1990 Jan; 140(1-2):46-9. PubMed ID: 2137956
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Role of the cardiac renin-angiotensin system in hypertensive heart disease].
    Holmer SR; Riegger GA
    Herz; 1995 Oct; 20(5):322-9. PubMed ID: 7498879
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [ACE-inhibitors and cardiovascular protection].
    Agabiti-Rosei E; Muiesan ML
    Cardiologia; 1994 Dec; 39(12 Suppl 1):139-47. PubMed ID: 7634257
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of angiotensin II blockade on cardiac hypertrophy and remodelling: a review.
    Dahlöf B
    J Hum Hypertens; 1995 Nov; 9 Suppl 5():S37-44. PubMed ID: 8583480
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Left ventricular remodeling and hypertension. Course with antihypertensive therapy].
    Ollivier JP
    Arch Mal Coeur Vaiss; 1991 Dec; 84 Spec No 4():73-7. PubMed ID: 1838922
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of renin-angiotensin system inhibition on end-organ protection: can we do better?
    Weir MR
    Clin Ther; 2007 Sep; 29(9):1803-24. PubMed ID: 18035185
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.